Loading clinical trials...
Loading clinical trials...
The study includes preterm infants who are being screened for ROP between August 1,2023 and August 1, 2024 in 94 neonatal intensive care units (NICUs) in Turkey. Infants with birth weight (BW) of \>15...
Keep your clinical trial research organized — questions to ask, what to expect, and key details.
Lead Sponsor
Baskent University Ankara Hospital
Collaborators
NCT07093255 · Retinopathy of Prematurity (ROP)
NCT06315556 · Retinopathy of Prematurity, Preterm Infants
NCT05558059 · Retinopathy of Prematurity
NCT06067958 · Retinopathy of Prematurity, Dexmedetomidine
NCT06694103 · Retinopathy of Prematurity (ROP)
Baskent University
Ankara
Use Clareo to keep notes, questions, trial details, and next steps organized before and after appointments.
Start free trial →Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions